Insider Aryeh Jason Buys Ligand Pharma Shares via Zero‑Cost RSU Grant – A Strong Confidence Signal
Jason’s $0‑price RSU buy of 836 Ligand shares signals strong insider confidence amid a 122% YTD surge, hinting at future upside for long‑term holders.
3 minutes to read